Q-Metrx, Inc. is a leading provider of high-quality neurophysiology data for clinical trials and drug development studies. With a team of experienced professionals, including registered EEG and PSG technologists, sleep specialists, neurologists, and PhD-trained experts in EEG analysis and neuroscience, Q-Metrx offers a comprehensive range of services, including polysomnography, sleep pupillometry, EEG screening, and quantitative EEG analysis. Their expertise in neurophysiological methods allows them to assess the safety, tolerability, and effects of new compounds on central nervous system activity, making them a trusted partner for CROs and pharmaceutical companies.
Founded in 1999 by Dr. Jack Johnstone, a renowned researcher in brain electrical activity and clinical neuroscience, Q-Metrx has grown from a small team to a well-established company with a strong track record. Their commitment to delivering accurate and reliable data, combined with their extensive experience in the field, has made them a go-to resource for companies seeking neurophysiological solutions for their clinical trials and proof-of-concept studies. Q-Metrx's dedication to excellence and their comprehensive range of services make them a valuable asset in the field of neurophysiology.
Generated from the website